The High Court has rejected plumbing company Repipe’s application to hear its case centred on the question of patent eligibility for computer-implemented inventions, saying the case was not an appropriate vehicle for special leave.
Bill Papas’ girlfriend Louise Agostino has hit back at Westpac’s lawsuit accusing her of involvement in the Forum Group director’s alleged $294 million fraud, denying all allegations and arguing that the bulk of the bank’s claims against her should be struck out.
Big Six firm Herbert Smith Freehills has appointed a PricewaterhouseCoopers veteran as its first director of global workforce strategy and implementation.
The nation’s peak body for barristers has lashed out at Prime Minister Scott Morrison for saying he has “never had much truck” with barristers during his political career and “didn’t care” if they disagreed with him about the need for a federal anti-corruption commission.
The behaviour of the legal team running the Banksia Securities class action was “reprehensible” and the solicitor who allowed himself to be controlled by lawyer and funder Mark Elliott should be struck from the court’s roll of practitioners, a judge heard Tuesday.
Eleven women will give evidence of sexually inappropriate behaviour by actor Craig McLachlan in his defamation case against Rocky Horror Show co-star Christie Whelan Browne and publishers ABC and Fairfax, including one actress who worked with him on the set of Neighbours in the late 1980s.
Moray & Agnew is facing a lawsuit by a former client who says the firm breached its duties by making an unauthorised $3.3 million transfer while representing him on an investment in a Melbourne storage facility development.
AMP has admitted two of its units charged customers fees for no service but denied it acted unconscionably in a case brought by the corporate regulator alleging it continued to charge advice fees and life insurance premiums to customers who had died.
Pharmaceutical giant Pfizer has fired off a lawsuit against four drug companies for allegedly infringing one of its patents for biologic Enbrel by selling a biosimilar of the blockbuster arthritis drug in Australia.
The corporate regulator has taken Australian Mines to court after its managing director was allegedly caught lying at an investment conference about the value of an offtake agreement and funding for a project at its cobalt and nickel mine in Queensland.
For information on rights and reprints, contact subscriptions@lawyerly.com.au
